Qi Huang

Qi Huang

Auto-generated profile, based on publicly available information

Qi Huang

PET Center, Huashan Hospital, Fudan University, Shanghai China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Cancer Letters
Verified
Journal Article
Closed access
TKTian-Shu Kang
Tian-Shu Kang
Wanhe WANGWanhe WANG
Wanhe WANG
HZHai-Jing Zhong
Hai-Jing Zhong
ZDZhen-Zhen Dong
Zhen-Zhen Dong
QHQi Huang
Qi Huang
Dik-Lung MaDik-Lung Ma
Dik-Lung Ma

1 September 2019 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
SASara Abdelfatah
Sara Abdelfatah
ABAngela Berg
Angela Berg
QHQi Huang
Qi Huang
LYLi Jun Yang
Li Jun Yang
SHSami Hamdoun
Sami Hamdoun
Thomas EfferthThomas Efferth
Thomas Efferth
Polo-like kinase (PLK1) has been identified as a potential target for cancer treatment. Although a number of small molecules have been investigated as PLK1 inhibitors, many of which showed limited selectivity. PLK1 harbors a regulatory domain, the Polo box domain (PBD), which has a key regulatory function for kinase activity and substrate recognition. We report on 3-bromomethyl-benzofuran-2-carboxylic acid ethyl ester (designated: MCC1019) as selective PLK1 inhibitor targeting PLK1 PBD. Cytotoxicity and fluorescence polarization-based screening were applied to a library of 1162 drug-like compounds to identify potential inhibitors of PLK1 PBD. The activity of compound MC1019 against the PLK1 PBD was confirmed using fluorescence polarization and microscale thermophoresis. This compound exerted specificity towards PLK1 over PLK2 and PLK3. MCC1019 showed cytotoxic activity in a panel of different cancer cell lines. Mechanistic investigations in A549 lung adenocarcinoma cells revealed that MCC1019 induced cell growth inhibition through inactivation of AKT signaling pathway, it also induced prolonged mitotic arrest-a phenomenon known as mitotic catastrophe, which is followed by immediate cell death via apoptosis and necroptosis. MCC1019 significantly inhibited tumor growth in vivo in a murine lung cancer model without affecting body weight or vital organ size, and reduced the growth of metastatic lesions in the lung. We propose MCC1019 as promising anti-cancer drug candidate.

25 February 2020 in Cellular & Molecular Immunology
Verified
Journal Article
Closed access
PDF file
NZNi Zhang
Ni Zhang
HZHui Zhang
Hui Zhang
BLBetty Yuen Kwan Law
Betty Yuen Kwan Law
IDIvo Ricardo De Seabra Rodrigues Dias
Ivo Ricardo De Seabra Rodrigues Dias
CQCong Ling Qiu
Cong Ling Qiu
LLLiang Liu
Liang Liu

13 December 2022 in Planta Medica
Verified
Journal Article
Closed access
PDF file
TGTing Gao
Ting Gao
YZYu Zhao
Yu Zhao
YZYuna Zhao
Yuna Zhao
YHYanping He
Yanping He
QHQi Huang
Qi Huang
Jing ChenJing Chen
Jing Chen
Radix arnebiae oil (RAO) is a clinically useful traditional Chinese medical formula with outstanding curative effects on burns. However, the mechanism of the effect of RAO on wound healing remains unclear. The present study investigates the molecular mechanisms of the potential curative effect of RAO on wound healing. The concentrations of the main constituents, shikonin, imperatorin, and ferulic acid in RAO detected by HPLC were 24.57, 3.15, and 0.13 mg/mL, respectively. A rat burn model was established, and macroscopic and histopathological studies were performed. RAO significantly accelerated wound closure and repair scarring, increased superoxide dismutase activities, and reduced malondialdehyde. RAO also downregulated interleukin (IL)-6, IL-1β and tumor necrosis factor-α in wound tissues and increased secretion of vascular endothelial growth factor, epidermal growth factor, and transforming growth factor (TGF)-β1. RAO increased the gene expression of TGF-β1, type I and III collagen, and increased the protein expression of TGF-β1 and phosphorylation of PI3K and Akt. In conclusion, RAO likely promotes wound healing via antioxidant and anti-inflammatory activities and increases re-epithelization. Activation of the TGF-β1/PI3K/Akt pathway may play an important role in the healing efficacy of RAO. These findings suggest that RAO could be a promising alternative local treatment for burn wound healing.

1 October 2019 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
QHQi Huang
Qi Huang
XZXiao-Hua Zhang
Xiao-Hua Zhang
LGLing-Ji Guo
Ling-Ji Guo
YHYu-Jun He
Yu-Jun He
Malignant melanoma of the breast (MMB) is a rare disease that accounts for 3–5% of all melanomas. It can be expressed as a metastatic mammary gland or primary mammary melanin of the mammary gland. Primary MMB (PMMB) can be divided into two types: parenchymal melanoma without skin involvement and melanoma involving skin on the breast. The diagnosis of PMMB relies mainly on histopathological diagnosis. In this diagnostic approach, S100 and HMB45 have a higher specificity in the diagnosis of melanoma immunohistochemistry. At the same time, mutations in the BRAF (V600E) gene have further aided the diagnosis of PMMB. After the diagnosis, the main treatment is mainly based on surgery. The main surgical methods include breast-conserving surgery and mastectomy. With advances in technology and surgical skills, the combination of patient aesthetic satisfaction and tumor safety is the goal of modern breast surgeons. This article reviews the current status of PMMB surgical treatment.